Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dalton, Zafgen Enter Manufacturing Pact | Contract Pharma
Breaking News

Dalton, Zafgen Enter Manufacturing Pact

Dalton Pharma Services has entered into a manufacturing services agreement with Zafgen, Inc. to provide cGMP aseptic fill/finish services and analytical support for Zafgen’s lead obesity treatment.

Dalton Pharma Services has entered into a manufacturing services agreement with Zafgen, Inc. to provide cGMP aseptic fill/finish services and analytical support for Zafgen’s lead obesity treatment.

“Adding Zafgen to our growing list of strategic relationships with innovative pharmaceutical clients is an important milestone for Dalton,” said Peter Pekos, Dalton Pharma’s president and chief executive officer. “We are thrilled to be working with the Zafgen team and look forward to a successful collaboration as we advance this breakthrough obesity therapy through clinical development.”

Thomas Hughes, chief executive officer of Zafgen, said, “The alliance with Dalton is a key part of our success in quickly advancing our first-in-class therapy for severe obesity into the next phase of clinical development. As a virtual company, Zafgen benefits tremendously from having the facilities and technical expertise found at Dalton. The opportunity to partner with a company that provides all aspects of manufacturing including the drug product and analytical services fits perfectly with Zafgen’s capital-efficient business model.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters